Porphyria Cutanea Tarda — Safety and Efficacy of Oral Deferasirox in Patients With Porphyria Cutanea Tarda
Citation(s)
A Phase II, Open Label Clinical Trial Exploring the Safety and the Efficacy of Oral Deferasirox in Patients Newly Diagnosed With Porphyria Cutanea Tarda (PCT) and Non-transfusion Iron Overload